News | January 09, 2025
Evonik partners with South Korean ST Pharm to increase its offerings for RNA and nucleic acid delivery
Increases speed to market for drug developers working on nucleic acid therapeutics
Increases speed to market for drug developers working on nucleic acid therapeutics
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
One thousand times more soluble than L-cystine at neutral pH
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
Subscribe To Our Newsletter & Stay Updated
